Australian and Chinese endoscopy announced that revenue for the first half of 2026 was 280 million yuan, an increase of 7.37% over the previous year. Net profit losses attributable to shareholders of listed companies were 85.6196 million yuan, compared to a loss of 407.652 million yuan in the same period last year.

Australian and Chinese endoscopy announced that revenue for the first half of 2026 was 280 million yuan, an increase of 7.37% over the previous year. Net profit losses attributable to shareholders of listed companies were 85.6196 million yuan, compared to a loss of 407.652 million yuan in the same period last year.